Presence of a Clinical Pharmacist in a Cardiology Department: What Impact on the Management of Diabetic Patients Within Care Pathways? Example of Inpatient Cardiac Patients at GHPSJ
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiomyopathy, Diabetic
- Sponsor
- Fondation Hôpital Saint-Joseph
- Enrollment
- 44
- Locations
- 1
- Primary Endpoint
- Measurement of biological test glycosylated haemoglobin evolution between the entrance and discharge
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The coverage of the diabetes is a multidisciplinary care, with practitioners' implication(hospital and liberal), and other medical and paramedical profession: doctor, pharmacist, male nurse, nutritionist, etc. In fact there is a real importance of link between hospital and general medecine outside. That's why the pharmacist's presence during the hospitalization seems to be a good alternative to make the link between hospital and the outside pharmacist where patient take his treatment.
Hospital pharmacis proceed to a treatment conciliation at the entrance and at discharge.
By this conciliation the aim of the study is to show and quantify the impact of pharmacist presence on therapeutic target .
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diabetes type 2 patient hospitalized in cardiology service
- •Hospitalization more than 24 hours
- •with insuline or/and oral anti diabetic
Exclusion Criteria
- •diabètes type 1
- •iatrogenic hyperglycaemia
- •hospitalization for cardia angiography
Outcomes
Primary Outcomes
Measurement of biological test glycosylated haemoglobin evolution between the entrance and discharge
Time Frame: 5 days